334 related articles for article (PubMed ID: 24252816)
21. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
23. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
24. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
25. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
[TBL] [Abstract][Full Text] [Related]
26. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
27. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
28. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of adrenal masses with MR imaging: comparison of techniques.
Reinig JW; Stutley JE; Leonhardt CM; Spicer KM; Margolis M; Caldwell CB
Radiology; 1994 Jul; 192(1):41-6. PubMed ID: 8208962
[TBL] [Abstract][Full Text] [Related]
30. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
33. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
[TBL] [Abstract][Full Text] [Related]
34. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: Utility of dynamic, contrast enhancement and single-shot T2-weighted sequences.
Becker-Weidman D; Kalb B; Mittal PK; Harri PA; Arif-Tiwari H; Farris AB; Chen Z; Sungjin K; Martin DR
Eur J Radiol; 2015 Nov; 84(11):2045-51. PubMed ID: 26233268
[TBL] [Abstract][Full Text] [Related]
36. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
[TBL] [Abstract][Full Text] [Related]
37. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis.
Chen J; Sun J; Xing W; Ding J; Chen T; Dai Y; Sun J; Hu J
Acta Radiol; 2014 Apr; 55(3):378-84. PubMed ID: 23946232
[TBL] [Abstract][Full Text] [Related]
38. [Adrenal tumors associated with renal cell carcinoma].
Ebina T; Umemura S; Sugimoto K; Minamisawa K; Miyajima E; Shionoiri H; Tochikubo O; Takeda M; Ishii M
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):841-7. PubMed ID: 2273601
[TBL] [Abstract][Full Text] [Related]
39. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images.
Ichikawa T; Ohtomo K; Uchiyama G; Koizumi K; Monzawa S; Oba H; Nogata Y; Kachi K; Toyama K; Yamaguchi M
Radiology; 1994 Oct; 193(1):247-50. PubMed ID: 8090900
[TBL] [Abstract][Full Text] [Related]
40. Diffusion tensor imaging in the differentiation of adrenal adenomas and metastases.
Işık Y; Gürses B; Taşdelen N; Kılıçkesmez O; Fırat Z; Ordu C; Gürmen N
Diagn Interv Radiol; 2012; 18(2):189-94. PubMed ID: 21960162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
